Tumor‐suppressor p53 gene in hepatitis C and B virus‐associated human hepatocellular carcinoma
- 19 June 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 54 (4), 558-562
- https://doi.org/10.1002/ijc.2910540407
Abstract
Abnormalities of the tumor-suppressor pS3 gene have been discovered in human hepatocellular carcinoma (HCC). It is unclear, however, whether HCC related to chronic viral hepatitis is associated with p53 gene alterations. In this study, we have examined pS3 abnormalities in HCC associated with hepatitis C and B virus (HCV and HBV) infections. Tissues from 18 HCC patients from several hospitals throughout the United States were collected (9 were HCV-infected, 5 were HBV-infected, I was HCV/HBV-infected, and 3 were non-virus-associated). Immunostaining with monoclonal pAb1801 revealed expression of p53 protein in tumor-cell nuclei in one HCV-associated HCC, and in no case of HBV-associated HCC, while the nuclei of adjacent hepatocytes were negative. Using Hae Ill-digestion of chromosomal DNA, mutations at codon 249 were not found in any of 18 HCC tissues studied. Direct sequencing demonstrated a mutated codon 244 and a wild-type codon 249 in the conserved regions (exon 5–8) of p53 gene from the tumor tissue with nuclear p53 expression. By reverse-transcription-polymer-ase chain reaction (RT-PCR), the expression of p53 mRNA was demonstrated in tumor cells from 10 out of 16 HCC tissues. In conclusion, the specific mutation at codon 249 with G to T transversion was not observed in the HCCs associated with HCV or HBV infections. In HBV or non-virus-associated HCCs studied, no other p53 gene abnormalities were found. A point mutation at codon 244 with G to A transition of p53 gene was detected in only one of 10 HCV-associated HCCs, which suggests that p53 mutations may not play a significant role in HCV- or HBV-associated hepatocarcinogenesis.Keywords
This publication has 13 references indexed in Scilit:
- Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.Proceedings of the National Academy of Sciences, 1992
- Hepatocellular carcinoma mutationNature, 1991
- Mutational hot spot in the p53 gene in human hepatocellular carcinomasNature, 1991
- Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 1991
- Prevalence of Antibody against Non‐A, non‐B Hepatitis Virus in Japanese Patients with Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1990
- Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.Molecular and Cellular Biology, 1989
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988
- Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsCell, 1979
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979